Outlook Therapeutics Stock Forecast

OTLK's stock price has decreased by -80.26% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts that cover Outlook Therapeutics stock have a consensus rating of "Buy" and an average price target of $2.50, which forecasts a 761.47% increase in the stock price over the next year. The lowest target is $0.50 and the highest is $6.00.

Price Target: $2.50 (+761.47%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$0.50	$2.50	$1.00	$6.00
Change	+72.29%	+761.47%	+244.59%	+1967.5%

* Price targets were last updated on Mar 11, 2026.

Analyst Ratings

The average analyst rating for Outlook Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $10 → $6	Strong Buy	Maintains	$10 → $6	+1,967.54%	Mar 11, 2026
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $0.5	Hold	Reiterates	$0.5	+72.29%	Feb 18, 2026
Daniil Gataulin Chardan Capital	Chardan Capital	Hold Maintains $1	Hold	Maintains	$1	+244.59%	Feb 18, 2026
Daniil Gataulin Chardan Capital	Chardan Capital	Hold Maintains $3 → $1	Hold	Maintains	$3 → $1	+244.59%	Jan 5, 2026
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $1 → $0.5	Hold	Maintains	$1 → $0.5	+72.29%	Jan 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

21.64M

from 1.41M

1,430.98%

from 1.41M

Revenue Next Year

59.13M

from 21.64M

173.23%

from 21.64M

EPS This Year

-0.53

from -1.79

EPS Next Year

-0.35

from -0.53

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026	Sep 30, 2027
Revenue	-	-	-	-	1.41M	21.64M	59.13M
Revenue Growth	-	-	-	-	-	1,430.98%	173.23%
EPS	-6.96	-6.23	-4.72	-4.06	-1.79	-0.53	-0.35
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	48.3M	139.3M
Avg	21.6M	59.1M
Low	8.5M	15.9M

Revenue Growth

Revenue Growth	2026	2027
High	3,318.6%	543.6%
Avg	1,431.0%	173.2%
Low	498.1%	-26.3%

EPS Forecast

EPS	2026	2027
High	-0.44	-0.22
Avg	-0.53	-0.35
Low	-0.61	-0.46

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.